|Day Low/High||354.90 / 361.64|
|52 Wk Low/High||281.20 / 401.50|
Insight on back-to-school; Apple's big news; and Best Buy's report.
As shoppers and retailers boost online activity, card companies' potential grows.
The company could vault into a leadership position in the mobile payments and banking industries. Over the past two weeks, I have participated in several meetings that reinforced my view that Monitise (MONI.L/MONIF) possesses architectural benefits ...
Betting that prices have bottomed off this crisis does seem more than a little glib.
The daily chart shows a two-step pattern that points to an upside target.
On a scale lower. Monitise (MONI.L/MONIF) is now trading near 60 pence in London. That is more than 10% under the price of the recent private placement purchased by Omega Adivsors, Mastercard (MA) and others. I am bidding on a scale lower.
Pharma giant Pfizer revealed Monday it made a $99 billion bid for AstraZeneca in January and had contacted its rival again on April 26 about a takeover.
This weekend's interview was one of the best and contains some good long-term investing ideas both long and short. My roots run deep with Barron's -- indeed, you might say I bleed Barron's blue. At 15 years of age I began to read Barron's, coinciden...
Prom spending has gone down for the first time since 2010, dropping more than 14% to $978 spent per family in 2014.
The big names paid a bit more for the shares during last week's private placement. Mastercard (MA), Omega Advisors et al. paid 68 pence for Monitise (MONI.L) in last week's private placement. This morning, Monitise is trading at 62.50 pence in Londo...
Wal-Mart is suing Visa for $5 billion for allegedly conspiring with banks to illegally fix and inflate credit card processing fees.
Another headline made. Mastercard (MA) and Monitise (MONI.L/MONIF) to partner to deliver digital payment services.